Eiko Lifesciences is currently trading at upper circuit limit of Rs. 74.60, up by 3.55 points or 5.00% from its previous closing of Rs. 71.05 on the BSE. The scrip opened at Rs. 73.98 and has touched a high and low of Rs. 74.60 and Rs. 73.00 respectively. So far 58227 shares were traded on
The researchers identified several promising drugs including the anticoagulant dicumarol, the gout medication benzbromarone, and two anti-inflammatory drugs, tolfenamic acid and diflunisal.